Project Grant R21NS144777
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$470K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Binghamton, NY 13902, USA
Similar Awards
This $424,875.00 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will fund a comprehensive study of gene transcription patterns in diverse classes of neurons that connect the brain to the spinal cord after spinal cord injury in a mouse model. The research team at Marquette University will use single-cell sequencing technologies to profile...
This $425,167 National Science Foundation (NSF) Engineering (CFDA 47.041) award to The Research Foundation for the State University of New York supports the development of a novel multifunctional soft neural probe technology. The goal is to use this new device to study the pathophysiology of spinal cord injuries and explore approaches to promote functional recovery. The award will fund the creation of soft polymer-based probes capable of optical stimulation, electrical recording, drug...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is supporting the development of a non-invasive infrared light therapy and medical device to treat spinal cord injury (SCI). The total award amount is $1,735,024.00 and the project period runs from August 15, 2024 to May 31, 2029. The primary objective is to develop an intervention that can...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $469,898.00 to Yale University to conduct research on mechanisms that support raphespinal tract plasticity and regeneration after spinal cord injury. The research aims to use anatomy, spatial transcriptomics, and intersectional in vivo chemogenetics to define the capacity and...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $151,559 to Rensselaer Polytechnic Institute (RPI) from August 3, 2024 to July 31, 2026. The project aims to develop innovative magnetically responsive drug delivery electrospun fibers to improve regeneration after spinal cord injury (SCI). Specifically, the research will focus...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $146,816 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program to the University of California, San Diego. The grant will fund research to simultaneously measure synaptic and spiking activity in corticospinal projection neurons in the primary motor cortex during the learning of a skilled motor task. The research aims to provide a deeper mechanistic...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $291,284 to Drexel University to conduct research on medial deep dorsal glycinergic interneurons and their role in improving locomotion following spinal cord injury. The key objectives are to identify the function of this specific population of inhibitory interneurons and...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $591,304.00 to the University of Louisville to conduct research on the role of the integrated stress response (ISR) pathway, particularly the kinase HRI, in oligodendrocyte death and neuroinflammation following traumatic spinal cord injury (SCI). The research aims to elucidate the...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports development of a novel screening technology to identify FDA-approved drugs that can promote functional recovery in spinal cord injury (SCI). The $411,136 award to the Texas A&M University System Health Science Center will fund a 3-step screening platform using adult cortical...
This $391,250 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program aims to develop effective therapeutic strategies for spinal cord injury (SCI) by evaluating controlled PTEN deletion and chondroitin sulfate proteoglycans (CSPGs) degradation to promote axon regeneration and functional recovery. The key objectives are to: 1) Temporally evaluate...